-
Abstract Number: PB1163
C20209T Prothrombin Gene Mutation in a Caucasian Woman with a History of Venous Thrombosis
-
Abstract Number: PB0320
Calculation of Fresh Frozen Plasma Amount to Correct Prolonged International Normalized Ratio
-
Abstract Number: OC 70.1
cAMP Prevents Antibody Induced Thrombus Formation in COVID-19
-
Abstract Number: PB1219
Can Combining a Risk Score Derived from Ubiquitous Biomarkers with a Clinical Risk Assessment Model Better Predict 90-day Post-discharge Hospital-associated Venous Thromboembolism among Medical Patients?
-
Abstract Number: PB0604
Can Plasminogen Activator Inhibitor 1 and Thrombin Activitable Fibrinolysis Inhibitor Explain Bleeding Phenotype in Hemophilia A?
-
Abstract Number: OC 65.1
Cancer is Associated with an Increased Stroke Risk in Patients with Atrial Fibrillation and CHA2DS2VASc Score ≤ 2
-
Abstract Number: PB0429
Cangrelor Long Term Prescription, Several Scenarios: A Case Report Series
-
Abstract Number: PB0838
Caplacizumab Rapidly Inhibits VWF-platelet Interaction: Pharmacodynamic Data from Healthy Volunteers and Patients with aTTP
-
Abstract Number: LPB0049
Cardiovascular Outcomes in Patients with Essential Thrombocythemia: Analysis of the National Inpatient Sample (NIS)
-
Abstract Number: PB1005
Case Report: Skin Necrosis in setting of Heparin and Warfarin Exposure
-
Abstract Number: OC 17.3
Case-fatality Rate of Major Bleeding Events among Patients Treated with Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-eluting Stent: A Systematic Review and Meta-analysis
-
Abstract Number: PB0808
Catastrophic Thrombotic Syndrome in 8 Year Old Boy: Clinical Case Report
-
Abstract Number: PB0291
CATS-MICA Score in Predicting Venous Thromboembolism in SARS-CoV-2-infected Cancer Patients
-
Abstract Number: OC 42.2
Cellular Factor XIII in Macrophage Derived Foam Cells
-
Abstract Number: LPB0076
Cerebral Sinovenous Thrombosis and Asparaginase Re-exposure in Patients Aged 1 to 45 Years with Acute Lymphoblastic Leukemia: A NOPHO ALL2008 Study
-
Abstract Number: PO171
Cerebral Thrombosis during Treatment of Childhood Acute Lymphoblastic Leukemia
-
Abstract Number: PB0279
Change in Platelet Indices in Patients with Coronavirus Infection Disease (COVID-19): A Reflection of Platelet Activation and Contribution to Immunothrombosis?
-
Abstract Number: PB0425
Changes in Plasminogen Binding and Cell Surface Properties in Streptococcus pyogenes in the Absence of Sortase A Are Due to Disruptions in Localization of M-protein
-
Abstract Number: OC 65.2
Changes in Prescription Patterns of Oral Anticoagulants and Clinical Outcomes among Newly Diagnosed Non-valvular Atrial Fibrillation Patients in the Netherlands
-
Abstract Number: PB0083
Changes in the Global Hemostatic Profile after Subarachnoid Aneurismatic Hemorrhage
-
Abstract Number: PB0529
Changes in Treatment Patterns in Patients with Severe Haemophilia – a Longitudinal Analysis of the Austrian Haemophilia Registry
-
Abstract Number: PB0027
Changes in Vascular Physiology in Patients with End Stage Renal Disease Compared to Patients with ESRD and Concomitant Cardiovascular Disease
-
Abstract Number: PB1019
Charactering the Role of TLT-1 in Inflammatory Pathogenesis of Obesity and Nonalcoholic Fatty Liver Disease (NAFLD)
-
Abstract Number: PB0025
Characterisation of Patients with Peripheral Artery Disease at Increased Risk for Cardiovascular Events and Mortality
-
Abstract Number: PB0755
Characteristics and Management of a Series of TAFRO Syndrome
-
Abstract Number: PB1091
Characteristics and Outcomes of Patients on Concurrent Direct Oral Anticoagulants and Targeted Anticancer Therapies – TacDOAC Registry
-
Abstract Number: PB0927
Characteristics and Treatment of Patients with von Willebrand Disease (VWD) in General Practice Settings in the United Kingdom
-
Abstract Number: PB0486
Characteristics of Anti-drug Antibody against Emicizumab Analyzed Using Hemophilia A Patient-derived Plasma Samples
-
Abstract Number: LPB0125
Characteristics of Pediatric Oncology Patients with Tumour Thrombus
-
Abstract Number: OC 31.4
Characterization of a New Family with Lifelong Macrothrombocytopenia Caused by a Novel Nonsense Variant in TPM4
-
Abstract Number: LPB0052
Characterization of Andexanet Alfa-associated Heparin Resistance: Implications for Management
-
Abstract Number: OC 52.2
Characterization of the Role of Integrin α5β1 in Platelet Function, Haemostasis and Arterial Thrombosis in Mice
-
Abstract Number: LPB0042
Characterization of Thrombotic Risk in Patients with Cancer
-
Abstract Number: PB0752
Chemotherapy Induced Thrombocytopenia: Is it Inducing Additional Social, Economic and Clinical Burden?
-
Abstract Number: PB0757
Chemotherapy-induced Thrombocytopenia and Platelet Transfusions in Hematology/Oncology Practice
-
Abstract Number: PB0782
Children with Bleeding and Clotting Disorders: Reviewing Quality of Life Tools
-
Abstract Number: OC 53.2
Children with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) Have a High Incidence of Acute Episodes: Data from the International Hereditary TTP Registry (IHTTP Registry)
-
Abstract Number: PB0607
Chinese Real-world Experience of Product Switching in Severe Hemophilia Patients: from rFVIII-FS(Kogenate®) to BAY 81-8973 (Kovaltry®)
-
Abstract Number: LPB0132
Chronic Edible Dosing of Δ9-tetrahydrocannabinol (THC) in Non-human Primates Reduces Systemic Platelet Activity and Function
-
Abstract Number: PB0756
Chronic Myeloid Leukemia with Extreme Thrombocytosis as Unusual Initial Presentation
-
Abstract Number: PB0311
Circulating Biologic Markers of Endothelial Dysfunction in Chronic Myeloproliferative Neoplasms
-
Abstract Number: PB0294
Circulating Biologic Markers of Endothelial Dysfunction in COVID-19 Patients
-
Abstract Number: LPB0103
Circulating Cellular Clusters Are Correlated with Thrombotic Complications and Clinical Outcomes in COVID-19
-
Abstract Number: PB1119
Circulating Extracellular Vesicles in Patients with Cancer and Venous Thromboembolism: A Systematic Review and Meta-analysis
-
Abstract Number: PB0164
Circulating Histones Are Associated with Disease Severity and Coagulopathy in COVID-19
-
Abstract Number: OC 68.2
Circulating Levels of Platelet, Endothelial and Red Blood Cell Microvesicles in COVID-19: Association with Biomarkers of Coagulation, Fibrinolysis and Angiogenesis
-
Abstract Number: PB0268
Circulating Nucleosome Immunoassay: Evaluating a Clinically-applicable Test to Risk Stratify COVID-19 and Target Anticoagulation
-
Abstract Number: OC 31.2
Clinical and Biological Assessment of the Largest Family with SRC-RT due to p.E527K Gain-of-Function Variant
-
Abstract Number: LPB0080
Clinical and Biological Assessment of the Second Pedigree Affected with X-linked GATA-1 Related Thrombocytopenia and Blood Group Lutheran Null
-
Abstract Number: PB0693
Clinical and Genetic Analysis of Nine Cases of Hereditary Factor V Deficiency
-
Abstract Number: PB1158
Clinical and Molecular Characterization of Chinese Patients with Protein S deficiency
-
Abstract Number: PB0409
Clinical and Molecular Characterization of Iranian Patients with Congenital Qualitative Fibrinogen Disorders
-
Abstract Number: PB0646
Clinical and Pharmacokinetic Assessment after Switching to an Extended Half-life Product for Prophylaxis in Haemophilia B
-
Abstract Number: PB0873
Clinical Application of Genetic Testing in Patients with Not Acquired Thrombocytopenia: One Center Experience
-
Abstract Number: PB0629
Clinical Assessment with the Evaluation of Joint Disease and Haemostatic Treatment in Patients with Severe Haemophilia B
-
Abstract Number: PB0473
Clinical Characteristics and Incidence of Inhibitors in Previously Untreated Children with Haemophilia: An Update of the Hemfil Cohort Study
-
Abstract Number: OC 44.1
Clinical Characteristics and Prognosis of Antiphospholipid Syndrome Patients Based on Cluster Analysis: A 10-year Cohort Study
-
Abstract Number: PB0433
Clinical Characteristics of Acquired Haemophilia A Patients in 5 European Countries
-
Abstract Number: PB0260
Clinical Course of COVID-19 in Patients with Inherited Bleeding Disorders: An Interim Analysis of 28 Cases
-
Abstract Number: PB1051
Clinical Course of Thrombotic Antiphospholipid Syndrome with Positive IgA Anticardiolipin or IgA β2-glycoprotein I
-
Abstract Number: PB0775
Clinical Factors Predicting Decrease in Hemoglobin Levels during Preoperative Autologous Blood Donation by Patients Undergoing Major Orthopedic Surgery
-
Abstract Number: PB0287
Clinical Impact of Immune Thrombocytopenic Purpura in the Context of SARS-CoV-2 Infection
-
Abstract Number: PB1185
Clinical Implications of V/Q SPECT Scans Being Inconclusive in 20% of Patients Referred on Suspicion of Pulmonary Embolism
-
Abstract Number: PB1216
Clinical Observations in Patients with Cerebral Venous Sinus Thrombosis
-
Abstract Number: PB0508
Clinical Outcomes after Joint Surgery in Patients on Turoctocog Alfa Pegol Prophylaxis
-
Abstract Number: PO116
Clinical Outcomes and Natural History of Critical Limb Ischemia: A Real World Experience
-
Abstract Number: OC 67.3
Clinical Outcomes in Adults with Hemophilia B with and without Pre-existing Neutralizing Antibodies to AAV5: 6 Month Data from the Phase 3 Etranacogene Dezaparvovec HOPE-B Gene Therapy Trial
-
Abstract Number: PB0195
Clinical Outcomes of Prophylactic vs. Therapeutic Doses of Anticoagulation In COVID-19 Patients: A Systematic Review and Meta-analysis
-
Abstract Number: PB0492
Clinical Profile and Bleeding Outcome of Pediatric Hemophilia A: The Royal Hospital’s Experience, Oman
-
Abstract Number: PB0717
Clinical Profile and Bleeding Outcome of Pediatric Rare Bleeding Disorders: The Royal Hospital’s Experience, Oman
-
Abstract Number: PB0314
Clinical Relevance of JAK2V617F on Patients with Philadelphia-negative Myeloproliferative Neoplasms
-
Abstract Number: PB1114
Clinical Risk Factors for Venous Thromboembolism in Hematologic Malignancies
-
Abstract Number: PB0654
Clinical Translatable Preconditioning for Platelet Gene Therapy in Murine Hemophilia A with Inhibitors
-
Abstract Number: OC 62.2
Clinical Value of Early Assessment of Hyperfibrinolysis by Rotational Thromboelastometry during Postpartum Hemorrhage for the Prediction of Severity of Bleeding: A Multicenter Prospective Cohort Study in the Netherlands
-
Abstract Number: PB0923
Clinical, Economic, and Quality of Life Burden Associated with von Willebrand Disease (VWD) in Adults and Children: Systematic and Targeted Literature Reviews
-
Abstract Number: LPB0118
Clinically Meaningful and Long-term Improvements in Fatigue with the C3 Inhibitor Pegcetacoplan In Paroxysmal Nocturnal Hemoglobinuria: Post-hoc Analyses from the PEGASUS Study Week 48
-
Abstract Number: PB1063
Clinico-pathologic Characterization of Patients Tested for Antiphospholipid Syndrome at a Tertiary Care Hospital
-
Abstract Number: PB0611
Clinicopathological Parameters and Influence of Blood Group and von Willebrand Factor (vWF) Levels on Residual Factor VIII (FVIII) Levels in Haemophilia A Patients
-
Abstract Number: PB0426
Co-delivery of Tissue Plasminogen Activator and Plasminogen Using Magnetically Powered Microwheels
-
Abstract Number: PO177
Coagulation Abnormalities At Presentation of Childhood Acute Lymphoblastic Leukemia
-
Abstract Number: PB0108
Coagulation Abnormalities in Patients without Congenital Bleeding Disorders: Analysis of Secondary Causes of Low Clotting Factors Levels
-
Abstract Number: PB0110
Coagulation Activity of Circulating Microparticles in Patients with Cardiovascular Diseases
-
Abstract Number: PB0977
Coagulation and Anticoagulation Factors Affecting Platelet Responses Independently of Thrombin and Fibrin
-
Abstract Number: LPB0071
Coagulation Factor 5 (F5) Is an Estrogen-responsive Gene in Breast Cancer Cells
-
Abstract Number: OC 77.2
Coagulation Factor XII Signaling via uPAR- β1 Integrin Promotes Renal Tubular Senescence in Diabetic Nephropathy
-
Abstract Number: PB1197
Coagulation Factors Levels during and after Anabolic Androgenic Steroid Use: Data from the HAARLEM Study
-
Abstract Number: PB0084
Coagulation Management Strategies in Cardiac Surgery: Viscoelastic tests
-
Abstract Number: PB0035
Coagulation Potential, Electrophysiological Characteristics and Structural Remodeling due to Atrial Fibrillation in Young and Aged Goats
-
Abstract Number: LPB0024
Coagulation-cancer Crosstalk; Von Willebrand Factor Contributes to Pro-invasive and Pro-angiogenic Properties in Breast Cancer Cells
-
Abstract Number: PB0740
Coagulopathy in Multiple Myeloma
-
Abstract Number: PB0232
Coagulopathy in Patients with Severe COVID-19
-
Abstract Number: PO148
Cocktail of Inherited Hemostatic and Red Cell Disorders in Unrelated Families of Interior Sindh
-
Abstract Number: PB1046
Collagen Turnover Biomarkers in Atrial Fibrillation and their Use in Clinical Management and the Study of Inflammatory Pathogenesis
-
Abstract Number: PB1031
Combined Antiplatelet Therapy Reduces the Pro-inflammatory Properties of Activated Platelets
-
Abstract Number: PB0009
Combined Focused Ultrasound and Electrohydraulic Shock Wave Thrombolytic Therapy Accompanied by Tissue Plasminogen Activator Administration Reduce Thrombus Content in the Arterial Atherothrombotic Stenosis
-
Abstract Number: PB0301
Combining Artificial Neural Networks and Blood Tests to Diagnose Covid-19 Infection
-
Abstract Number: PB0051
Combining Heparin with a FX/FXa Aptamer to Reduce Thrombin Generation in Models of Cardiopulmonary Bypass and COVID-19 Associated Coagulopathy
-
Abstract Number: PB1013
Common Cardiovascular Disease Polygenic Risk Scores for Arterial and Venous Disease Influence Different Platelet Reactivity Tests
-
Abstract Number: PB0379
Comparability of PT Determination with STA-NeoPTimal on STart and STart Max Semi-automated Instruments
-
Abstract Number: OC 56.2
Comparative Analysis of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B-domain Favours Readthrough-mediated Protein Output
-
Abstract Number: PB1083
Comparative Effectiveness of Alternative Bridging Therapies for Subtherapeutic INR in Patients with Left Ventricular Assist Devices
-
Abstract Number: PB1250
Comparative Effectiveness of Oral Anticoagulants in Venous Thromboembolism: On-treatment Analysis in GARFIELD-VTE
-
Abstract Number: PB0471
Comparative Recovery of FVIII Antigen with Various FVIII Therapeutic Concentrates Using an Improved 2nd Generation ELISA Kit
-
Abstract Number: PB0633
Compare the Efficacy and Safety of Low-dose and Intermediate-dose Prophylactic Therapy in Adult Patients with Severe Hemophilia A, a Self-control Study
-
Abstract Number: PB1177
Comparing “Clinical Hunch” against Clinical Decision Scores (PERC Rule, Wells Score, Revised Geneva Score, YEARS Criteria) in Acute Pulmonary Embolism Diagnostics
-
Abstract Number: PB1222
Comparing Adherence of Low Molecular Weight Heparin versus Unfractionated Heparin for Thromboprophylaxis of Medical Inpatients
-
Abstract Number: PB0047
Comparing the Real-world and Clinical Trial Bleeding Rates Associated with Anticoagulation Treatment for Atrial Fibrillation
-
Abstract Number: PB0390
Comparison between Coagulation Factor Deficiencies versus Pharmacological Inhibition of Activated Coagulation Factors Using Clot Waveform Analysis
-
Abstract Number: PB1218
Comparison of 0.9% Normal Saline (NS) Flush and Unfractionated Heparin (UFH) Flush for Maintenance of Central Venous Catheter Line Patency
-
Abstract Number: PB0101
Comparison of a Chromogenic vs. APTT-based Factor VIII Activity Assay in the Recovery of a Pegylated Factor VIII Replacement Therapy in Plasma Samples
-
Abstract Number: OC 45.2
Comparison of Alternative Viscoelastic Hemostatic Assays – Rotational Thromboelastometry versus Sonorheometry for Rapid Diagnosis in Trauma Patients: An Interim Analysis
-
Abstract Number: LPB0015
Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration
-
Abstract Number: PB0344
Comparison of Peak Plasma Concentrations of Apixaban in Adolescent and Adult Patients
-
Abstract Number: PB0348
Comparison of Platelet Counts Using Impedance, Optical and CD61-immunoplatelet Methods in Thrombocytopenic Patients
-
Abstract Number: PB0004
Comparison of Platelet Function Tests during P2Y12 Inhibition
-
Abstract Number: PB0368
Comparison of PT/INR Assessment with STA-NeoPTimal on an Automated and Semi-automated Test Platform
-
Abstract Number: PB1263
Comparison of Real-world Effectiveness and Safety of Enoxaparin versus Tinzaparin or Dalteparin in Cancer Patients with Venous Thromboembolism. The RIETECAT Cohort Study
-
Abstract Number: PB0730
Comparison of the Relative PAR1, PAR2 and PAR3 Cleavage Profiles by Thrombin, APC, Factor Xa and Factor VIIa
-
Abstract Number: PB0383
Comparison of Visual Interpretation of the DOAC Dipstick Test with a Reader System for Rapid and Accurate Detection of Direct Oral Anticoagulants in Neurology and Cardiology – Interim Data from a Prospective Consecutive Comparative Study
-
Abstract Number: PB0617
Comprehensive Genotype Characterization in Non-severe Hemophilia A. Mutational Profile and Assessment of the Bleeding Phenotype in Argentine Patients
-
Abstract Number: PB1132
Concurrent Atypical Thrombotic Complications of Acute Promyelocytic Leukemia (APL) in an Anticoagulated Patient: A Rare Case Report
-
Abstract Number: PB0690
Concurrent Use of Tranexamic Acid and Hormonal Therapy: Management of Heavy Menstrual Bleeding in Women with Inherited Bleeding Disorders
-
Abstract Number: PB0935
Congenital Bleeding Disorders in Adolescent Females Evaluated for Menorrhagia and Iron Deficiency Anemia
-
Abstract Number: PB0716
Congenital Factor Vii Deficiency and Vacterl Association: An Unusual Combination
-
Abstract Number: PB0704
Congenital Factor XI Deficiency: A Single-center Retrospective Analysis of 80 Cases
-
Abstract Number: PB0644
Consistency Analysis and Data Validation Regarding Hospitalization among Hemophilic Patients from the Hemophilia Center of the Hematology Service of HC FMUSP – (2008-2018)
-
Abstract Number: OC 64.1
Contact Activation and Coagulation in Residual Venous Obstruction
-
Abstract Number: PB0141
Contact System and Intrinsic Pathway Are Activated and Associated with Clinical and Laboratory Outcomes in COVID-19 Patients
-
Abstract Number: PB0094
Control of Anti-coagulant Treatment in Patients with Acute Stroke by the Results of the «Thrombodynamics» Test
-
Abstract Number: OC 42.3
Controlled Knockdown of Fibrinogen with siRNA Modulates Fibrinogen-mediated Inflammation
-
Abstract Number: OC 02.2
Controlled Long-term Knockdown of Plasminogen in Mice and Dogs using siRNA: Assessment of Phenotype and Toxicity
-
Abstract Number: PB0376
Correlation between Plasma Levels, Anti-FXa Activity and Coagulation Parameters in Real-world Patients on Treatment with Edoxaban
-
Abstract Number: LPB0120
Correlation between Procoagulant Platelets and Hypercoagulability in Lung Cancer Patients
-
Abstract Number: PB0750
Correlation between Serum PDGF-CC Levels with Clinical Stage of Colorectal Cancer
-
Abstract Number: PB0354
Correlation between the Rosner Index with the Etiological Diagnosis of the Prolongation of the Activated Partial Thromboplastin Time (aPTT) in Asymptomatic Presurgical Patients
-
Abstract Number: PB0264
Correlation of Coagulation Parameters with Prognosis of COVID-19
-
Abstract Number: PB0947
Correlation of VWF:Ab to VWF:Ag Ratio and Abnormal VWF Multimer Pattern
-
Abstract Number: PB0678
Cost-effectiveness Analysis of the Brazilian Immune Tolerance Induction Protocol with Recombinant Factor VIII and Prophylaxis with Bypassing Agents or Emicizumab
-
Abstract Number: PB0341
Cost-effectiveness of a Stepwise versus an All-in-One Approach to Diagnose Mild Bleeding Disorders
-
Abstract Number: PB0600
Cost-effectiveness of rFVIII Single-chain in an Italian Population of Hemophilia A Patients: The Veneto Experience
-
Abstract Number: PB1050
Could the Adjusted Version of the Global Antiphospholipid Syndrome Score (aGAPSS) Be a Useful Tool to Select Patients with Primary Obstetric Antiphospholipid Syndrome (POAPS) for Primary Thromboprophylaxis with Aspirin?
-
Abstract Number: PB1097
Could Thromboprophylaxis Influence the Clinical Course of Patients with Active Cancer? Preliminary Results from the ACT4CAT Study
-
Abstract Number: PO138
COVID-19 and Coagulation Abnormalities Diagnostic Dilemma
-
Abstract Number: NUR 01.2
COVID-19 and its Impact on the Pediatric Bleeding Disorders Population: Soaring BMIs
-
Abstract Number: PB0194
COVID-19 and Patients with Hemorrhagic Congenital Disease: Experience from Regional Heamophilia Treatment Center of Strasbourg (France)
-
Abstract Number: PB0178
COVID-19 Diagnosis and its Impact on Thrombotic Risk in a Cohort of Consecutive Patients Hospitalized due to Severe Acute Respiratory Syndrome
-
Abstract Number: PB0179
COVID-19 Infection is Associated with Antibody-mediated Procoagulant Platelets: Data from an Observational Study
-
Abstract Number: PB0188
COVID-19 Pneumonia Worse Prognosis Related to Lupus Anticoagulant Transient Positive Test
-
Abstract Number: PB0183
COVID-19 Related Abnormalities in the Hematologic Characteristics among Inpatient Children. Results of the PICNIC Registry
-
Abstract Number: PB0177
COVID-19 Vaccination and Anticoagulation: Potential Effects on Anticoagulation Control in Patients Using Vitamin K Antagonists
-
Abstract Number: PB0165
COVID-19-Related Thrombosis in Japan: Results of a Questionnaire-based Survey in 2020
-
Abstract Number: OC 29.3
CRISPR Edited Megakaryocytes for Rapid Screening of Platelet Gene Functions
-
Abstract Number: PB0255
Cross-talk between the Inflammatory Response and Coagulopathy: Single-center Report
-
Abstract Number: OC 01.1
Crosstalk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H
-
Abstract Number: OC 42.4
Cryoprecipitate Transfusion Significantly Decreases the Rate of Plasmin Generation in Trauma Patients
-
Abstract Number: OC 26.2
Cryoprecipitate, and Not Fibrinogen Concentrate, Enhances Early Clot Formation in an in vitro Microfluidic Model of Dilutional Coagulopathy
-
Abstract Number: OC 05.1
Crystal Structure of Factor IXa with an Anticoagulant Aptamer Bound to an Allosteric Site
-
Abstract Number: OC 09.2
Crystal Structure of the von Willebrand Factor A1 Domain – Caplacizumab Complex
-
Abstract Number: PB1105
Cumulative Incidence of Recurrent Venous Thromboembolism by Cancer and Provoking Status – A Population-based Study
-
Abstract Number: PB1028
Curcumin Inhibits Platelets by Activation of Adenosine A2 Receptor and cAMP/PKA Pathway
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.